Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
<p><strong>Aims</strong> Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains uncertain whether there is clinically relevant genetic variation in their efficacy. This study of 18 705 individuals aims to identify genetic variants related to the lipi...
Main Authors: | Hopewell, J, Parish, S, Offer, A, Link, E, Clarke, R, Lathrop, M, Armitage, J, Collins, R |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Oxford University Press
2013
|
פריטים דומים
-
Genetic variation in lipid response to statin therapy in 18,705 participants in the heart protection study
מאת: Hopewell, J, et al.
יצא לאור: (2011) -
No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
מאת: Hopewell, J, et al.
יצא לאור: (2011) -
Lipoprotein(a) Genetic Variants Associated With Risk of Atherothrombotic Disease in 14,465 Participants From the Heart Protection Study
מאת: Hopewell, J, et al.
יצא לאור: (2010) -
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom
מאת: Hopewell, JC, et al.
יצא לאור: (2020) -
Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study.
מאת: Hopewell, J, et al.
יצא לאור: (2011)